Inside a Modern Semaglutide (Ozempic) Facility From Peptides to Weight Loss Pens

Описание: 🧬 INSIDE SEMAGLUTIDE PRODUCTION

Journey inside the pharmaceutical facility producing Semaglutide, the active ingredient in weight loss and diabetes medications including Ozempic and Wegovy.

From peptide synthesis to pre-filled injection devices, witness every stage of the GLP-1 receptor agonist manufacturing process that has transformed diabetes and obesity treatment worldwide.

⏱️ CHAPTERS:
00:00 - Introduction
00:08 - Facility Overview and Biosafety Protocols
00:40 - Peptide Synthesis Laboratory
01:28 - Solid-Phase Peptide Synthesis SPPS
02:48 - Amino Acid Chain Assembly
04:16 - Cleavage and Deprotection
05:36 - HPLC Purification Process
07:04 - Lyophilization Freeze-Drying
08:24 - Formulation and Compounding
09:44 - Sterile Filtration Systems
10:56 - Syringe Filling Operations
12:16 - Quality Control and Potency Testing
13:28 - Device Assembly
14:40 - Final Packaging and Cold Chain
15:52 - Distribution and Logistics
16:44 - Conclusion

📊 PRODUCTION AT SCALE:
Semaglutide: GLP-1 receptor agonist peptide with 31 amino acids
Used for Type 2 diabetes and chronic weight management
Peptide synthesis via solid-phase methodology
Purification to over 99 percent pharmaceutical purity
Sterile filling in controlled environment ISO Class 5 cleanroom
Pre-filled injection devices 0.25mg, 0.5mg, 1mg, 2mg doses
Cold chain storage required 2-8°C throughout distribution
Weekly subcutaneous injection regimen
FDA approved for diabetes in 2017 and weight loss in 2021

🔬 SCIENTIFIC BACKGROUND:
Semaglutide is a glucagon-like peptide-1 or GLP-1 receptor agonist used to treat type 2 diabetes and obesity. It works by mimicking the GLP-1 hormone, stimulating insulin secretion, reducing appetite, and slowing gastric emptying. The medication has shown significant efficacy in clinical trials for both glycemic control and weight reduction.

Brand names include Ozempic for diabetes, Wegovy for weight management, and Rybelsus as oral form. The manufacturing process requires advanced biotechnology including solid-phase peptide synthesis, sophisticated purification techniques, and sterile pharmaceutical production under stringent regulatory standards.

💉 MANUFACTURING HIGHLIGHTS:
Peptide synthesis: 31 amino acid sequence assembly
Chain length: 4,113 daltons molecular weight
Purification: Multi-step HPLC with over 99 percent purity requirement
Formulation: pH-controlled solution with stabilizers
Filling: Automated sterile filling 1.5ml or 3ml cartridges
Device: Pre-filled injection system for patient use
Testing: Potency, purity, sterility, endotoxin verification
Storage: Refrigerated cold chain throughout distribution

🎯 ABOUT INSIDE PHARMA:
This documentary series explores pharmaceutical and biotechnology manufacturing at industrial scale. We document real production processes showing how modern medications are made.

Episode 1: COVID-19 mRNA Vaccine Production
Episode 2: Sildenafil Tablet Production
Episode 3: Semaglutide GLP-1 Weight Loss Drug - This video
Episode 4: Coming soon.

🔔 SUBSCRIBE for pharmaceutical and biotech manufacturing documentaries


#Semaglutide #Ozempic #Wegovy #WeightLoss #GLP1 #DiabetesMedication #PharmaceuticalManufacturing #PeptideSynthesis #Biotechnology #InsidePharma #PeptideProduction #WeightLossInjection #DiabetesTreatment #PharmaceuticalIndustry #Documentary



DISCLAIMER: This video is for educational purposes documenting pharmaceutical manufacturing processes. Semaglutide, Ozempic, and Wegovy are registered trademarks of Novo Nordisk. This video is not sponsored by or affiliated with Novo Nordisk. All information presented is for educational documentation of pharmaceutical manufacturing techniques. Consult healthcare professionals regarding medical treatment decisions.